Clinical Trials · NCT04917484
Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Tine Gregersen, MD
- Enrollment
- 100
- Start date
- Feb 2020
- Locations
- 1 site, Denmark
- Primary endpoint
- Progression free survival